An overexpression of N-RAS or WT1 was observed in advanced stages of MDS, and a down-regulation of CDKN2B as a result of promoter hypermethylation was associated with leukemic transformation in MDS [4,7–10]. The gene discussed is WT1; the disease is myelodysplastic syndrome.